Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Erin Newman
Observed names:
Erin M Newman,
Erin M. Newman
Institution:
Alkahest, Inc. (United States)
Observed institution:
Alkahest, Inc. (United States)
ORCID:
0000-0001-7510-2544
Observed ORCID:
0000-0001-7510-2544
OpenAlex ID:
A5064259947
Safety and Therapeutic Effects of Orally Administered Akst4290 in Newly Diagnosed Neovascular Age-related Macular Degeneration
2022
·
Michael W. Stewart
, Seema Garg
, et al.
·
Retina
·
27
Rationale and Design of a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AKST4290 in Subjects with Parkinson’s Disease on Stable Dopaminergic Treatment (4430)
2020
·
Jessica Powell
, Esther Rawner
, et al.
·
Neurology
·
1
Phase 2 Trial Results of Topically Administered ILYX-002, a Novel Immune Modulator for Inflammatory and Autoimmune Dry Eye Disease
2025
·
Alissa Maillet
, James Armitage
, et al.
·
Figshare
Show more works
View as search
Works count:
3
Citation count:
28
H-index:
1
I10-index:
1
Year
Topic
Type